News headlines about Innophos (NASDAQ:IPHS) have trended somewhat positive recently, according to Accern. The research group identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Innophos earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news stories about the specialty chemicals company an impact score of 45.7033711240761 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Several equities research analysts recently commented on IPHS shares. BidaskClub cut Innophos from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th. Zacks Investment Research upgraded Innophos from a “hold” rating to a “buy” rating and set a $50.00 price objective for the company in a research report on Friday, December 15th. Finally, KeyCorp restated a “hold” rating on shares of Innophos in a research report on Wednesday, November 1st.

Innophos (NASDAQ:IPHS) opened at $46.51 on Thursday. The company has a market capitalization of $908.29, a price-to-earnings ratio of 21.33 and a beta of 0.85. Innophos has a 52-week low of $41.66 and a 52-week high of $58.22. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86.

Innophos (NASDAQ:IPHS) last released its earnings results on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.06. The firm had revenue of $184.00 million during the quarter, compared to analyst estimates of $179.33 million. Innophos had a return on equity of 13.90% and a net margin of 6.19%. Innophos’s revenue was down 1.1% compared to the same quarter last year. During the same period last year, the business posted $0.69 earnings per share. equities research analysts predict that Innophos will post 2.5 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, December 6th. Shareholders of record on Friday, November 17th were paid a $0.48 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 4.13%. The ex-dividend date was Thursday, November 16th. Innophos’s dividend payout ratio is presently 88.07%.

ILLEGAL ACTIVITY NOTICE: “Innophos (IPHS) Earns News Impact Score of 0.19” was reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://theolympiareport.com/2017/12/28/innophos-iphs-earns-news-impact-score-of-0-19.html.

About Innophos

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Insider Buying and Selling by Quarter for Innophos (NASDAQ:IPHS)

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with Analyst Ratings Network's FREE daily email newsletter.